参考文献/References:
[1]Wu C,Xie N,Lian Y,et al.Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia[J].Springerplus,2016(5):431. [2]Mika J,Zychowska M,Popiolek-Barczyk K.et al.Importance of glial activation in neuropathic pain[J].Eur J Pharmacol,2013,716(1-3):106-119.[3]Safarpour Y,Jabbari B.Botulinum toxin treatment of pain syndromes-an evidence based review[J].Toxicon,2018(147):120-128.[4]Hatch MN,Cushing TR,Carlson GD,et al.Neuropathic pain and SCI: Identification and treatment strategies in the 21st century[J].J Neurol Sci,2017(384):75-83.[5]Wu T,Song H,Dong Y,et al.Intra-articular injections of botulinum toxin a for refractory joint pain:A systematic review and meta-analysis[J].Clin Rehabil,2017,31(4):435-443. [6]Ondo WG,Simmons JH,Shahid MH,et al.Onabotulinum toxin-A injections for sleep bruxism:A double-blind,placebo-controlled study[J].Treatment,2018,90(7):e559-e564.[7]Wang J,Casals-Diaz L,Zurawski T,et al.A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain[J].Neuropharmacology,2017,118(8):223-232. [8]Burstein R,Zhang XC,Levy D,et al.Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A:Therapeutic implications for migraine and other pains[J].Cephalalgia,2014(34):853-869. [9]Hoeij FB,Tack JF,Pandolfino JE,et al.Complications of botulinum toxin injections for treatment of esophageal motility disorders[J].Dis Esophagus,2017,30(1):1-5.[10]Cho SJ,Song TJ,Chu MK.Treatment Update of Chronic Migraine[J].Curr Pain Headache Rep,2017,21(6):26.[11]Sousa EJS,Sousa GC,Baia VF,et al.Botulinum toxin type A in chronic neuropathic pain in refractory leprosy[J].Arq Neuropsiquiatr,2019,77(5):346-351.[12]Castillo-álvarez F,Hernando de la Bárcena I,Marzo-Sola ME.Botulinum toxin in trigeminal neuralgia[J].Med Clin(Barc),2017,148(1):28-32.[13]Arbizu RA,Rodriguez L.Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children[J].World J Gastrointest Endosc,2015,7(5):433-437.[14]Alviar MJM,Hale T,Dungca M.Pharmacologic interventions for treating phantom limb pain[J].Cochrane Database Syst Rev,2016,10(10):CD006380.[15]Zychowska M,Rojewska E,Makuch W,et al.Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain[J].Eur J Pharmacol,2016(791):377-388.[16]Vacca V,Marinelli S,Luvisetto S.Botulinum toxin A increases analgesic effects of morphine,counters development of morphine tolerance and modulates glial activation and μ opioid receptor expression in neuropathic mice[J].Brain Behav Immun,2013(32):40-50. [17]Tsuda M,Koga K,Chen T,et al.Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex[J].J Neurochem,2017,141(4):486-498.[18]Choi BJ,Imlach WL,Jiao W,et al.Miniature Neurotransmission Regulates Drosophila Synaptic Structural Maturation[J].Neuron,2014,82(3):618-634.[19]Südhof TC,Rothman JE.Membrane fusion:Grappling with SNARE and SM proteins[J].Science,2009,323(5913):474-477.[20]Pantano S,Montecucco C.The blockade of the neurotransmitter release apparatus by botulinum neurotoxins[J].Cell Mol Life Sci,2014,71(5):793-811. [21]Intiso D,Basciani M,Santamato A,et al.Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation[J].Toxins(Basel),2015,7(7):2454-2480.[22]Welch MJ,Purkiss JR,Foster KA.Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins[J].Toxicon,2000,38(2):245-258. [23]Ochoa Vargas DC.Efficacy of Botulinum toxin A for the treatment of Bladder pain syndrome:A systematic review[J].Actas Urol Esp,2018,42(3):152-162.[24]Drinovac Vlah V,Bach-Rojecky L.Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain[J].J Neural Transm(Vienna),2016,123(12):1403-1413. [25]Wiegand H,Erdmann G,Wellh?ner HH.125I-Labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection[J].Naunyn Schmiedebergs Arch Pharmacol,1976(292):161-165. [26]Caleo M,Restani L.Direct central nervous system effects of botulinum neurotoxin[J].Toxicon,2018(147):68-72.[27]Marinelli S,Vacca V,Ricordy R,et al.The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes[J].PLoS One,2012,7(10):e47977.[28]Piotrowska A,Popiolek-Barczyk K,Pavone F,et al.Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures[J].Front Cell Infect Microbiol,2017(7):147. [29]Hepp R,Perraut M,Chasserot-Golaz S,et al.Cultured glial cells express the SNAP-25 analogue SNAP-23[J].Glia,1999,27(2):181-187.[30]Zhang Y,Chen J,Ji H,et al.Protective effects of Danshen injection against erectile dysfunction via suppression of endoplasmic reticulum stress activation in a streptozotocin-induced diabetic rat model[J].BMC Complement Altern Med,2018,18(1):343.[31]Roh DH,Yoon SY,Seo HS,et al.Intrathecal injection of carbenoxolone,a gap junction decoupler,attenuates the induction of below-level neuropathic pain after spinal cord injury in rats[J].Exp Neurol,2010,224(1):123-132.[32]Panatier A,Vallée J,Haber M,et al.Astrocytes are endogenous regulators of basal transmission at central synapses[J].Cell,2011,146(5):785-798.[33]Popiolek-Barczyk K,Mika J.Targeting the microglial signaling pathways:New insights in the modulation of neuropathic pain[J].Curr Med Chem,2016,23(26):2908-2928.[34]Tanga FY,Raghavendra V,DeLeo JA.Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain[J].Neurochem Int,2004,45(2-3):397-407.[35]Mika J,Osikowicz M,Makuch W,et al.Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain[J].Eur J Pharmacol,2007,560(2-3):142-149.[36]Mika J,Rojewska E,Makuch W,et al.The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord[J].Neuroscience,2011(175):358-366.[37]Kim YJ,Kim JH,Lee KJ,et al.Botulinum Neurotoxin Type A Induces TLR2-Mediated Inflammatory Responses in Macrophages[J].PLoS One,2015,10(4):e0120840.[38]Popiolek-Barczyk K,Kolosowska N,Piotrowska A,et al.Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy[J].Neural Plast,2015(2015),676473.[39]Piotrowska A,Kwiatkowski K,Rojewska E,et al.Maraviroc reduces neuropathic pain through polarization of microglia and astroglia-Evidence from in vivo and in vitro studies[J].Neuropharmacology,2016(108):207-219.[40]Jurga AM,Rojewska E,Piotrowska A,et al.Blockadeoftoll-like receptors(TLR2,TLR4)attenuates pain and potentiates buprenorphine analgesia in a rat neuropathic pain model[J].Neural Plast,2016(2016),5238730.[41]Liu T,Gao YJ,Ji RR.Emerging role of Toll-likereceptors in the control of pain and itch[J].Neurosci Bull,2012,28(2):131-144.[42]Kigerl KA,Rivero JP,Dietrich WD,et al.Patternrecognitionreceptors and central nervous system repair[J].Exp Neurol,2014(258):5-16.[43]Nair-Gupta P,Baccarini A,Tung N,et al.TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation[J].Cell,2014,158(3):506-521.[44]Beauvillain C,Donnou S,Jarry U,et al.Neonatal and adult microglia cross-present exogenous antigens[J].Glia,2008,56(1):69-77.[45]HolmTH,DraebyD,Owens T.Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response[J].Glia,2012,60(4):630-638.[46]Lin Y,Lee H,Berg AH,et al.The lollipopaccharide-activated Toll-like receptor(TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes[J].J Biol Chem,2000,275(32):24255-24263.